Phathom Pharmaceuticals
PHAT
PHAT
103 hedge funds and large institutions have $613M invested in Phathom Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
105% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 20
23% more funds holding
Funds holding: 84 → 103 (+19)
4.79% more ownership
Funds ownership: 73.35% → 78.15% (+4.8%)
Holders
103
Holding in Top 10
5
Calls
$6.18M
Puts
$638K
Top Buyers
| 1 | +$24.4M | |
| 2 | +$18.3M | |
| 3 | +$18.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$16.5M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$15M |
Top Sellers
| 1 | -$3.54M | |
| 2 | -$2.83M | |
| 3 | -$2.46M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.42M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.19M |